Description: KetamineOne Capital Limited, a next generation wellness company, focuses on ketamine assisted therapy and psychedelic medicines through operating healthcare clinics in North America. The company was formerly known as Myconic Capital Corp. and changed its name to KetamineOne Capital Limited in June 2021. KetamineOne Capital Limited was founded in 2017 and is headquartered in Vancouver, Canada.
Home Page: www.ketamine.one
1917 West 4th Avenue
Vancouver,
BC
V6J 1M7
Canada
Phone:
Officers
| Name | Title |
|---|---|
| Ms. Najla Guthrie | CEO, Chief Research Officer & Director |
| Mr. Terry Zimaro C.A., CPA | Chief Financial Officer |
| Natalie Dolphin | VP of Marketing & Investment Relations |
| Mr. Keith White | Pres of Clinic Operations |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.9481 |
| Price-to-Sales TTM: | 6.7407 |
| IPO Date: | |
| Fiscal Year End: | July |
| Full Time Employees: | 0 |